Combining 2.5 milligrams of diphenoxylate and 0.025 mg of atropine sulfate.
When it comes to reducing gastrointestinal motility, diphenoxylate is 8–10 times more effective than morphine.
Each oral tablet contains 2.5 mg of diphenoxylate hydrochloride and 0.025 mg of atropine sulfate.
Mechanism of action:
Opioid receptor agonist
Bind to u receptor on the Myenteric Plexus of GIT.
Stimulation of this receptor will lead to:
Lessen the tone of cells that make up longitudinal smooth muscles.
Increase the tone of circular smooth muscle cells to lengthen transit time.
Increase the intestine's ability and time to absorb water while inhibiting the gastric reflex.
Indication:
Associated with inflammatory bowel disease is nonspecific diarrhea.
Dose:
Adult:
2 tabs qid untill diarrhoea is controlled.
Child:
Above 6 yrs: Dosage calculated as 0.25 mg Diphenoxylate HCI per kg daily in divided doses.
Contraindication:
Hypersensitivity to Diphenoxylate and Atropine.
Side effects:
Sedation, tachycardia, drowsiness, restlessness, headache, dizziness, nausea, vomiting abdominal discomfort, thrust, paralysis of ileum, dryness of skin, dryness of mucus membrane, respiratory depression, urinary retention.
Nursing considerations:
With a full glass of water, administer medication. Encourage patients to drink enough fluids while they are taking atropine and diphenoxylate to prevent dehydration.
Keep the medication out of reach of children. A child may die from an overdose of atropine plus diphenoxylate.
Keep an eye on the stools' regularity and consistency. If you experience fever, bloody stools, palpitations, or any other negative side effects, call your doctor right away.
Driving and other potentially risky activities should be avoided until the treatment reaction is determined.
Without first seeing a doctor, avoid breastfeeding while taking this medication.
Should not be administered along with alcohol or CNS depressants.
Check your bowel movements for peristalsis, which can lead to paralytic ileus.
Loperamide:
Mechanism of action:
Through the direct reduction of peristaltic activity,loperamide decreases intestinal motility. reduces the volume of the faces and modifies the colon's reabsorption of water and electrolytes.
Indication:
Associated with inflammatory bowel disease is nonspecific diarrhea.
Dose:
Adult: Initially 4mg followed by 2mg after each loose motion. Maximum 6mg / day
Contraindication:
Severe liver disease, children under 2 years of age, infections diarrhoea, pseudomembranous colities.